美股市场个股详情
ARTV Artiva Biotherapeutics
- 12.600
- +0.390+3.19%
收盘价 11/27 16:00 (美东)
- 12.600
- 0.0000.00%
盘后 16:02 (美东)
3.06亿总市值-4994市盈率TTM
12.920最高价12.365最低价2.65万股成交量12.370今开12.210昨收33.40万成交额0.19%换手率亏损市盈率(静)2428.93万总股本17.31052周最高1.52市净率1.75亿流通值9.68052周最低--股息TTM1392.00万流通股17.310历史最高--股息率TTM4.55%振幅9.680历史最低12.619平均价1股每手
关于Artiva Biotherapeutics公司
Artiva Biotherapeutics Inc 是一家生物制药公司。该公司致力于推进现成的、同种异体NK细胞疗法的管道，用于治疗血液恶性肿瘤或实体肿瘤。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。
公司介绍
公司代码ARTV
公司名称Artiva Biotherapeutics
上市日期2024/07/19
发行价格12.00
成立日期2019
CEODr. Fred Aslan, M.D.
所属市场纳斯达克
员工数量81
年结日12-31
公司地址5505 Morehouse Drive,Suite 100
城市San Diego
省份加利福尼亚州
国家美国
邮编92121
电话1-858-267-4467
董事高管
- 姓名
- 职务
- 年薪
- Dr. Fred Aslan, M.D.
- President, Chief Executive Officer and Director
- 110.78万
- Neha Krishnamohan
- Executive Vice President, Corporate Development, Chief Financial Officer and Principal Accounting Officer
- --
- Christopher Horan
- Chief Technical Operations Officer
- 72.69万
- Jennifer Kinsbruner Bush
- Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer
- 72.58万
- Thorsten Graef, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Heather Raymon, PhD
- Senior Vice President, Research and Early Development
- --
- Dr. Brian Daniels,M.D.
- Chairman of the Board
- --
- Dr. Alison Moore, PhD
- Director
- --
- James Jong-eun Park
- Director
- --
- Dr. Diego Miralles, M.D.
- Director
- --
- Yong-Jun Huh
- Director
- --
- Dr. Yvonne Yamanaka, PhD
- Independent Director
- --
- Elizabeth L. Hougen
- Independent Director
- --
- Dr. Laura Stoppel, PhD
- Independent Director
- --
- Dr. Laura Bessen, M.D.
- Independent Director
- --
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
